Aspen Grove Capital’s Neogen NEOG Stock Holding History

Aspen Grove Capital’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,155	Closed	-$88K	–	260
2025 Q1	$88K	Buy	+10,155	New	+$106K	0.02%	230

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Aspen Grove Capital's NEOG Position: Q2 2025 in Review

Aspen Grove Capital sold out of Neogen (NEOG) in Q2 2025, closing a stake of 10,155 shares — an estimated $88K sold.

Aspen Grove Capital first reported a position in NEOG in Q1 2025 and held it in 1 quarter. The position peaked at $88K in Q1 2025. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2025.

Aspen Grove Capital reported no remaining Neogen position as of Q2 2025 after selling out during the quarter.
Aspen Grove Capital sold 10,155 Neogen shares in Q2 2025, an estimated $88K.
Aspen Grove Capital first reported a position in Neogen in Q1 2025 and held it in 1 quarter.
Aspen Grove Capital's Neogen position peaked at $88K in Q1 2025.
317 funds tracked by Wall St. Rank held Neogen as of Q2 2025.

Based on Aspen Grove Capital's 13F filing for Q2 2025, filed 14 Aug 2025.